Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum
Miromatrix Medical Inc. is set to present its pioneering bioengineering technology at the Bioregate European Regenerative Medicine Forum from September 21-23, 2022, in Louvain-la-Neuve, Belgium.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Miromatrix Medical Inc. is set to present its pioneering bioengineering technology at the Bioregate European Regenerative Medicine Forum from September 21-23, 2022, in Louvain-la-Neuve, Belgium. CEO Jeff Ross will deliver the keynote speech on September 21 at 3:05 pm CEST. The event focuses on the themes of repair, replacement, regeneration, and reprogramming in regenerative medicine, organized by several prestigious universities and organizations. Miromatrix aims to address the shortage of transplantable human organs, focusing on liver and kidney bioengineering.
Details
News Market Reaction – MIRO
The recorded move for MIRO in the trading session of this news was -6.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced CEO Jeff Ross will present at the Bioregate European Regenerative Medicine Forum. The conference, held this year on September 21-23 in Louvain-la-Neuve, Belgium, is dedicated to the 4R Medicine, Repair, Replacement, Regeneration, and Reprogramming.
Mr. Ross will be a keynote speaker at the Bioregate European Regenerative Medicine Forum on September 21st, 2022 at 3:05 pm CEST.
The event is organized by Nantes University, the Catholic University of Louvain and Atlanpole Biotherapies, with the support of the University of Liège, FlandersBio, BioWin, Wallonie-Bruxelles International, FNRS, the Region of Pays de la Loire and Nantes Métropole.
About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.
Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com
Media Contact:
press@miromatrix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.